1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Muchmore, S.W.
Sattler, M.
Liang, H.
Meadows, R.P.
Harlan, J.E.
Yoon, H.S.
Nettesheim, D.
Chang, B.S.
Thompson, C.B.
Wong, S.L.
Ng, S.C.
Fesik, S.W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Nature
NATUAS
0006
0028-0836
381
335
341
10.1038/381335a0
8692274
X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
1996
10.2210/pdb1lxl/pdb
pdb_00001lxl
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
24879.371
BCL-XL
RESIDUES 1-209, LACKING THE C-TERMINAL HYDROPHOBIC REGION
1
man
polymer
APOPTOSIS REGULATOR BCL-X
no
no
MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLD
AREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVD
KEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH
MSMAMSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLD
AREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVD
KEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERLEHHHHHH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Human
Escherichia
sample
9606
Homo sapiens
562
Escherichia coli
HMS174 (DE3)
plasmid
PET29B
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-04-21
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1996-04-04
REL
NMR SPECTRA WERE RECORDED ON 1-3 MM SOLUTIONS OF BCL-XL IN 20 MM SODIUM PHOSPHATE BUFFER (PH 7.3), 5 MM DTT AND 1MM EDTA AT 303K.
1
7.3
303
K
BRUNGER
refinement
X-PLOR
3.1
MET
-3
n
1
MET
-3
A
SER
-2
n
2
SER
-2
A
MET
-1
n
3
MET
-1
A
ALA
0
n
4
ALA
0
A
MET
1
n
5
MET
1
A
SER
2
n
6
SER
2
A
GLN
3
n
7
GLN
3
A
SER
4
n
8
SER
4
A
ASN
5
n
9
ASN
5
A
ARG
6
n
10
ARG
6
A
GLU
7
n
11
GLU
7
A
LEU
8
n
12
LEU
8
A
VAL
9
n
13
VAL
9
A
VAL
10
n
14
VAL
10
A
ASP
11
n
15
ASP
11
A
PHE
12
n
16
PHE
12
A
LEU
13
n
17
LEU
13
A
SER
14
n
18
SER
14
A
TYR
15
n
19
TYR
15
A
LYS
16
n
20
LYS
16
A
LEU
17
n
21
LEU
17
A
SER
18
n
22
SER
18
A
GLN
19
n
23
GLN
19
A
LYS
20
n
24
LYS
20
A
GLY
21
n
25
GLY
21
A
TYR
22
n
26
TYR
22
A
SER
23
n
27
SER
23
A
TRP
24
n
28
TRP
24
A
SER
25
n
29
SER
25
A
GLN
26
n
30
GLN
26
A
PHE
27
n
31
PHE
27
A
SER
28
n
32
SER
28
A
ASP
29
n
33
ASP
29
A
VAL
30
n
34
VAL
30
A
GLU
31
n
35
GLU
31
A
GLU
32
n
36
GLU
32
A
ASN
33
n
37
ASN
33
A
ARG
34
n
38
ARG
34
A
THR
35
n
39
THR
35
A
GLU
36
n
40
GLU
36
A
ALA
37
n
41
ALA
37
A
PRO
38
n
42
PRO
38
A
GLU
39
n
43
GLU
39
A
GLY
40
n
44
GLY
40
A
THR
41
n
45
THR
41
A
GLU
42
n
46
GLU
42
A
SER
43
n
47
SER
43
A
GLU
44
n
48
GLU
44
A
MET
45
n
49
MET
45
A
GLU
46
n
50
GLU
46
A
THR
47
n
51
THR
47
A
PRO
48
n
52
PRO
48
A
SER
49
n
53
SER
49
A
ALA
50
n
54
ALA
50
A
ILE
51
n
55
ILE
51
A
ASN
52
n
56
ASN
52
A
GLY
53
n
57
GLY
53
A
ASN
54
n
58
ASN
54
A
PRO
55
n
59
PRO
55
A
SER
56
n
60
SER
56
A
TRP
57
n
61
TRP
57
A
HIS
58
n
62
HIS
58
A
LEU
59
n
63
LEU
59
A
ALA
60
n
64
ALA
60
A
ASP
61
n
65
ASP
61
A
SER
62
n
66
SER
62
A
PRO
63
n
67
PRO
63
A
ALA
64
n
68
ALA
64
A
VAL
65
n
69
VAL
65
A
ASN
66
n
70
ASN
66
A
GLY
67
n
71
GLY
67
A
ALA
68
n
72
ALA
68
A
THR
69
n
73
THR
69
A
GLY
70
n
74
GLY
70
A
HIS
71
n
75
HIS
71
A
SER
72
n
76
SER
72
A
SER
73
n
77
SER
73
A
SER
74
n
78
SER
74
A
LEU
75
n
79
LEU
75
A
ASP
76
n
80
ASP
76
A
ALA
77
n
81
ALA
77
A
ARG
78
n
82
ARG
78
A
GLU
79
n
83
GLU
79
A
VAL
80
n
84
VAL
80
A
ILE
81
n
85
ILE
81
A
PRO
82
n
86
PRO
82
A
MET
83
n
87
MET
83
A
ALA
84
n
88
ALA
84
A
ALA
85
n
89
ALA
85
A
VAL
86
n
90
VAL
86
A
LYS
87
n
91
LYS
87
A
GLN
88
n
92
GLN
88
A
ALA
89
n
93
ALA
89
A
LEU
90
n
94
LEU
90
A
ARG
91
n
95
ARG
91
A
GLU
92
n
96
GLU
92
A
ALA
93
n
97
ALA
93
A
GLY
94
n
98
GLY
94
A
ASP
95
n
99
ASP
95
A
GLU
96
n
100
GLU
96
A
PHE
97
n
101
PHE
97
A
GLU
98
n
102
GLU
98
A
LEU
99
n
103
LEU
99
A
ARG
100
n
104
ARG
100
A
TYR
101
n
105
TYR
101
A
ARG
102
n
106
ARG
102
A
ARG
103
n
107
ARG
103
A
ALA
104
n
108
ALA
104
A
PHE
105
n
109
PHE
105
A
SER
106
n
110
SER
106
A
ASP
107
n
111
ASP
107
A
LEU
108
n
112
LEU
108
A
THR
109
n
113
THR
109
A
SER
110
n
114
SER
110
A
GLN
111
n
115
GLN
111
A
LEU
112
n
116
LEU
112
A
HIS
113
n
117
HIS
113
A
ILE
114
n
118
ILE
114
A
THR
115
n
119
THR
115
A
PRO
116
n
120
PRO
116
A
GLY
117
n
121
GLY
117
A
THR
118
n
122
THR
118
A
ALA
119
n
123
ALA
119
A
TYR
120
n
124
TYR
120
A
GLN
121
n
125
GLN
121
A
SER
122
n
126
SER
122
A
PHE
123
n
127
PHE
123
A
GLU
124
n
128
GLU
124
A
GLN
125
n
129
GLN
125
A
VAL
126
n
130
VAL
126
A
VAL
127
n
131
VAL
127
A
ASN
128
n
132
ASN
128
A
GLU
129
n
133
GLU
129
A
LEU
130
n
134
LEU
130
A
PHE
131
n
135
PHE
131
A
ARG
132
n
136
ARG
132
A
ASP
133
n
137
ASP
133
A
GLY
134
n
138
GLY
134
A
VAL
135
n
139
VAL
135
A
ASN
136
n
140
ASN
136
A
TRP
137
n
141
TRP
137
A
GLY
138
n
142
GLY
138
A
ARG
139
n
143
ARG
139
A
ILE
140
n
144
ILE
140
A
VAL
141
n
145
VAL
141
A
ALA
142
n
146
ALA
142
A
PHE
143
n
147
PHE
143
A
PHE
144
n
148
PHE
144
A
SER
145
n
149
SER
145
A
PHE
146
n
150
PHE
146
A
GLY
147
n
151
GLY
147
A
GLY
148
n
152
GLY
148
A
ALA
149
n
153
ALA
149
A
LEU
150
n
154
LEU
150
A
CYS
151
n
155
CYS
151
A
VAL
152
n
156
VAL
152
A
GLU
153
n
157
GLU
153
A
SER
154
n
158
SER
154
A
VAL
155
n
159
VAL
155
A
ASP
156
n
160
ASP
156
A
LYS
157
n
161
LYS
157
A
GLU
158
n
162
GLU
158
A
MET
159
n
163
MET
159
A
GLN
160
n
164
GLN
160
A
VAL
161
n
165
VAL
161
A
LEU
162
n
166
LEU
162
A
VAL
163
n
167
VAL
163
A
SER
164
n
168
SER
164
A
ARG
165
n
169
ARG
165
A
ILE
166
n
170
ILE
166
A
ALA
167
n
171
ALA
167
A
ALA
168
n
172
ALA
168
A
TRP
169
n
173
TRP
169
A
MET
170
n
174
MET
170
A
ALA
171
n
175
ALA
171
A
THR
172
n
176
THR
172
A
TYR
173
n
177
TYR
173
A
LEU
174
n
178
LEU
174
A
ASN
175
n
179
ASN
175
A
ASP
176
n
180
ASP
176
A
HIS
177
n
181
HIS
177
A
LEU
178
n
182
LEU
178
A
GLU
179
n
183
GLU
179
A
PRO
180
n
184
PRO
180
A
TRP
181
n
185
TRP
181
A
ILE
182
n
186
ILE
182
A
GLN
183
n
187
GLN
183
A
GLU
184
n
188
GLU
184
A
ASN
185
n
189
ASN
185
A
GLY
186
n
190
GLY
186
A
GLY
187
n
191
GLY
187
A
TRP
188
n
192
TRP
188
A
ASP
189
n
193
ASP
189
A
THR
190
n
194
THR
190
A
PHE
191
n
195
PHE
191
A
VAL
192
n
196
VAL
192
A
GLU
193
n
197
GLU
193
A
LEU
194
n
198
LEU
194
A
TYR
195
n
199
TYR
195
A
GLY
196
n
200
GLY
196
A
ASN
197
n
201
ASN
197
A
ASN
198
n
202
ASN
198
A
ALA
199
n
203
ALA
199
A
ALA
200
n
204
ALA
200
A
ALA
201
n
205
ALA
201
A
GLU
202
n
206
GLU
202
A
SER
203
n
207
SER
203
A
ARG
204
n
208
ARG
204
A
LYS
205
n
209
LYS
205
A
GLY
206
n
210
GLY
206
A
GLN
207
n
211
GLN
207
A
GLU
208
n
212
GLU
208
A
ARG
209
n
213
ARG
209
A
LEU
210
n
214
LEU
210
A
GLU
211
n
215
GLU
211
A
HIS
212
n
216
HIS
212
A
HIS
213
n
217
HIS
213
A
HIS
214
n
218
HIS
214
A
HIS
215
n
219
HIS
215
A
HIS
216
n
220
HIS
216
A
HIS
217
n
221
HIS
217
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
6
0.186
SIDE CHAIN
1
A
ARG
34
0.172
SIDE CHAIN
1
A
ARG
78
0.258
SIDE CHAIN
1
A
ARG
91
0.237
SIDE CHAIN
1
A
ARG
100
0.317
SIDE CHAIN
1
A
ARG
102
0.312
SIDE CHAIN
1
A
ARG
103
0.318
SIDE CHAIN
1
A
ARG
132
0.202
SIDE CHAIN
1
A
ARG
139
0.207
SIDE CHAIN
1
A
ARG
165
0.302
SIDE CHAIN
1
A
ARG
204
0.215
SIDE CHAIN
1
A
ARG
209
0.191
SIDE CHAIN
1
A
SER
-2
-147.66
31.87
1
A
ALA
0
-179.24
-51.73
1
A
PHE
27
-101.22
-68.66
1
A
SER
28
83.86
-45.21
1
A
VAL
30
-127.32
-148.71
1
A
ASN
33
58.96
174.20
1
A
ARG
34
54.88
-176.87
1
A
GLU
36
-153.46
24.72
1
A
THR
41
-145.92
-48.01
1
A
GLU
44
-159.62
-36.20
1
A
MET
45
55.91
179.12
1
A
SER
49
171.48
37.84
1
A
ALA
50
173.63
-77.94
1
A
ILE
51
40.10
90.75
1
A
ASN
52
-54.43
173.18
1
A
ASN
54
-179.10
71.16
1
A
PRO
55
-83.87
46.12
1
A
TRP
57
-97.40
-69.97
1
A
HIS
58
38.61
33.16
1
A
LEU
59
77.59
-77.36
1
A
ASP
61
-160.99
30.51
1
A
ALA
64
58.23
-91.25
1
A
ASN
66
64.65
111.74
1
A
ALA
68
-114.39
-77.32
1
A
HIS
71
75.43
-2.90
1
A
SER
72
-158.27
31.10
1
A
SER
73
175.02
-44.35
1
A
SER
74
-63.69
-162.93
1
A
LEU
75
58.34
103.32
1
A
ALA
77
-132.93
-45.48
1
A
VAL
80
40.90
-159.03
1
A
MET
83
168.92
-79.59
1
A
ALA
84
57.27
-90.61
1
A
ARG
100
-122.03
-168.59
1
A
TYR
101
79.71
-72.41
1
A
ARG
102
78.99
-75.50
1
A
ARG
103
-65.55
-153.87
1
A
ALA
104
79.87
-73.64
1
A
GLN
111
-97.63
38.89
1
A
LEU
112
-155.24
-64.15
1
A
HIS
113
65.26
73.10
1
A
THR
115
179.73
168.76
1
A
PRO
116
-52.86
99.85
1
A
THR
118
-52.08
174.34
1
A
ALA
119
-164.23
-159.80
1
A
GLN
121
-67.28
-77.20
1
A
VAL
135
51.36
70.60
1
A
HIS
177
-147.01
-53.08
1
A
ASN
198
-54.54
-77.77
1
A
ALA
199
177.30
44.02
1
A
GLU
202
-129.04
-64.67
1
A
GLN
207
-163.59
42.78
1
A
GLU
208
77.33
-76.22
1
A
ARG
209
174.96
-34.98
1
A
LEU
210
67.95
-86.90
1
A
GLU
211
-173.65
100.59
1
A
HIS
213
-179.09
36.20
1
A
HIS
214
65.83
130.03
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH, MINIMIZED AVERAGE STRUCTURE
1
Y
N
A
GLU
7
A
GLU
11
HELX_P
A
LYS
20
A
LYS
24
1
1
14
A
ALA
85
A
ALA
89
HELX_P
A
GLU
98
A
GLU
102
1
2
14
A
PHE
105
A
PHE
109
HELX_P
A
LEU
112
A
LEU
116
1
3
8
A
TYR
120
A
TYR
124
HELX_P
A
PHE
131
A
PHE
135
1
4
12
A
TRP
137
A
TRP
141
HELX_P
A
VAL
155
A
VAL
159
1
5
19
A
VAL
163
A
VAL
167
HELX_P
A
GLU
184
A
GLU
188
1
6
22
A
TRP
188
A
TRP
192
HELX_P
A
LEU
194
A
LEU
198
1
7
7
APOPTOSIS
APOPTOSIS, PROGRAMMED CELL DEATH, BCL-2 FAMILY
BCLX_HUMAN
UNP
1
1
Q07817
MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREV
IPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQ
VLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK
1
209
1LXL
1
209
Q07817
A
1
5
213
1
P 1